Trial Profile
A Multicenter Study Investigating the Treatment Outcomes of Ledipasvir/Sofosbuvir (LDV/SOF) Combination Regimen in Mongolian Patients with Hepatitis C Virus (HCV) Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 17 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018.